Cell therapy for secondary progressive multiple sclerosis
Part of Brain & nervous system, Immune system & allergy clinical trials.
This trial tests a new cell therapy (NG01) for people with secondary progressive multiple sclerosis. It aims to see if the treatment can slow or stop disability progression. Participation involves multiple clinic visits and MRI scans.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 65 years old.
- You have been diagnosed with secondary progressive multiple sclerosis (SPMS).
- Your disability has worsened over the past 2 years, as measured by standard tests (EDSS or walking speed).
- Your disability level at screening is moderate, ranging from 3.5 to 6.5 on the EDSS scale.
- You can walk 25 feet (about 7.6 meters) in 8 to 25 seconds.
- You have not had a relapse in the last 2 years, and you have no active lesions on a recent MRI.
- You are not pregnant or breastfeeding, and if you can get pregnant, you agree to use effective contraception.
- You are not currently taking any other experimental treatment, and you have been on your current MS medication for at least 6 months.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests whether stem cells from donated fat tissue can slow down primary progressive multiple sclerosis. You would receive a single injection of the cells into your spinal fluid and be followed for up to 2 years.
This study tests an experimental treatment called C-CAR168, which uses your own immune cells that have been modified to target and potentially slow down the progression of multiple sclerosis. It is for younger adults with progressive MS who have not responded well to standard treatments.
This trial tests a new way to treat primary progressive multiple sclerosis (PPMS) using a stem cell transplant from a healthy donor. The goal is to see if this approach can stop or slow the disease and improve quality of life.
This study tests a new treatment that combines a type of immune cell therapy with a targeted antibody to see if it can help people with multiple sclerosis. It aims to reduce the immune system's attack on the nervous system and potentially slow disease progression.
This trial uses your own blood stem cells to reboot your immune system, which may help stop multiple sclerosis attacks and slow disability. It is for people with active MS that has not responded well to other treatments.
This Phase 1/2 trial studies whether donated umbilical cord stem cells are safe and can improve multiple sclerosis. It aims to see if the treatment is workable for people who still have active MS despite standard therapies.
Hear when a new Secondary Progressive Multiple Sclerosis (SPMS) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.